Today's top medical abstracts
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: VGX-1027 To Undergo Additional Testing For RA
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: FDA Approves Actemra
D Scott Cunningham MD, PhD, MDLinx Rheumatology
From the Editors: New Clinical-Only Option for MDLinx!
Stephen Smith, MDLinx
  See all
Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Diagnostic and prognostic significance of measuring antibodies to &alpha fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary sjögren's syndrome
Journal of Rheumatology, 03/20/08
Print     Email This Article     Save in My Library   Free Abstract
Locht H et al. - A higher specificity or sensitivity of &alpha -fodrin antibody compared to anti-Ro/La could not be confirmed in this study. Furthermore, anti-La antibodies were strongly correlated to organ involvement and cytopenias, and thus could serve as a prognostic marker in primary Sjögren's syndrome (pSS).

Methods
  • Aim was to to (1) compare sensitivity and specificity of different autoantibodies in pts with pSS. (2) Data on internal organ manifestations were correlated with presence of autoantibodies
  • Clinical and laboratory data was collected from 321 pts with pSS
  • Sera were tested for autoantibodies against &alpha -fodrin and recombinant Ro-52, Ro-60, and La proteins

Results
  • Antibodies to &alpha -fodrin were not diagnostically superior to conventional anti-Ro/La testing
  • IgG anti-La had the highest specificity
  • An association was found between presence of anti-La and internal organ manifestations or hematological abnormalities
  • The pattern of autoantibodies was relatively independent of disease duration
  • This indicated that these antibodies appeared early in pSS, probably even years before the first symptoms were manifest

Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.